150 related articles for article (PubMed ID: 27328744)
1. Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.
Aralaguppe SG; Winner D; Singh K; Sarafianos SG; Quiñones-Mateu ME; Sönnerborg A; Neogi U
J Med Virol; 2017 Jan; 89(1):106-111. PubMed ID: 27328744
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness.
van Domselaar R; Njenda DT; Rao R; Sönnerborg A; Singh K; Neogi U
J Virol; 2019 May; 93(9):. PubMed ID: 30760577
[TBL] [Abstract][Full Text] [Related]
3. The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa.
Sharma S; Aralaguppe SG; Abrahams MR; Williamson C; Gray C; Balakrishnan P; Saravanan S; Murugavel KG; Solomon S; Ranga U
BMC Infect Dis; 2017 Jan; 17(1):95. PubMed ID: 28118816
[TBL] [Abstract][Full Text] [Related]
4. PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C.
Sharma S; Arunachalam PS; Menon M; Ragupathy V; Satya RV; Jebaraj J; Aralaguppe SG; Rao C; Pal S; Saravanan S; Murugavel KG; Balakrishnan P; Solomon S; Hewlett I; Ranga U
J Biol Chem; 2018 Jul; 293(30):11687-11708. PubMed ID: 29773649
[TBL] [Abstract][Full Text] [Related]
5. Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa.
Neogi U; Engelbrecht S; Claassen M; Jacobs GB; van Zyl G; Preiser W; Sonnerborg A
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):80-4. PubMed ID: 26413747
[TBL] [Abstract][Full Text] [Related]
6. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
7. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.
Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T
Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315
[TBL] [Abstract][Full Text] [Related]
8. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.
Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
Martins AN; Waheed AA; Ablan SD; Huang W; Newton A; Petropoulos CJ; Brindeiro RD; Freed EO
J Virol; 2016 Jan; 90(2):768-79. PubMed ID: 26512081
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic co-receptor tropism and Maraviroc sensitivity in HIV-1 subtype C from East Africa.
Siddik AB; Haas A; Rahman MS; Aralaguppe SG; Amogne W; Bader J; Klimkait T; Neogi U
Sci Rep; 2018 Feb; 8(1):2363. PubMed ID: 29403064
[TBL] [Abstract][Full Text] [Related]
11. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
[TBL] [Abstract][Full Text] [Related]
12. Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients.
Neogi U; Rao SD; Bontell I; Verheyen J; Rao VR; Gore SC; Soni N; Shet A; Schülter E; Ekstrand ML; Wondwossen A; Kaiser R; Madhusudhan MS; Prasad VR; Sonnerborg A
AIDS; 2014 Sep; 28(15):2319-22. PubMed ID: 25102091
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping.
Robinson LH; Gale CV; Kleim JP
J Virol Methods; 2002 Jul; 104(2):147-60. PubMed ID: 12088824
[TBL] [Abstract][Full Text] [Related]
14. PYRE insertion within HIV-1 subtype C p6-Gag functions as an ALIX-dependent late domain.
Chaturbhuj D; Patil A; Gangakhedkar R
Sci Rep; 2018 Jun; 8(1):8917. PubMed ID: 29891975
[TBL] [Abstract][Full Text] [Related]
15. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.
Peters S; Muñoz M; Yerly S; Sanchez-Merino V; Lopez-Galindez C; Perrin L; Larder B; Cmarko D; Fakan S; Meylan P; Telenti A
J Virol; 2001 Oct; 75(20):9644-53. PubMed ID: 11559796
[TBL] [Abstract][Full Text] [Related]
16. Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.
Ho SK; Coman RM; Bunger JC; Rose SL; O'Brien P; Munoz I; Dunn BM; Sleasman JW; Goodenow MM
Virology; 2008 Sep; 378(2):272-81. PubMed ID: 18599104
[TBL] [Abstract][Full Text] [Related]
17. Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.
Verheyen J; Litau E; Sing T; Däumer M; Balduin M; Oette M; Fätkenheuer G; Rockstroh JK; Schuldenzucker U; Hoffmann D; Pfister H; Kaiser R
Antivir Ther; 2006; 11(7):879-87. PubMed ID: 17302250
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
[TBL] [Abstract][Full Text] [Related]
19. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.
Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761
[TBL] [Abstract][Full Text] [Related]
20. Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy.
Ibe S; Shibata N; Utsumi M; Kaneda T
Microbiol Immunol; 2003; 47(1):71-9. PubMed ID: 12636256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
